Chronic myeloid leukemia (CML) is a type of leukemia in which too many white cells are produced and overtake a person’s bone marrow. There is also an abnormal chromosome present called the Philadelphia chromosome.
In CML, patients have an abnormal chromosome in their blood cells called the Philadelphia chromosome, which was discovered at Penn.
CML is chronic, slow-growing and takes longer to develop. There are some rare cases in which CML can progress into acute leukemia, which needs immediate medical attention.
CML can be treated by our Leukemia Program.
Every step of cancer treatment, from a cancer diagnosis and treatment, to forming a survivorship plan, comes with different needs and issues that should be addressed.
Oncology navigators are committed to making sure every patient experience is as comfortable as possible. They are experts in navigating complex healthcare situations and serve as a consistent point of contact and a reliable source for advice, support and direction for patients and families.